Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-15 Francis Richard D President and CEO Option exercise 10b5-1 +161,655 161,655
2024-02-15 Francis Richard D President and CEO Sale 10b5-1 −74,530 $13.15 $980K 87,125
2024-02-15 Francis Richard D President and CEO Option exercise · Restricted Share Units 10b5-1 −161,655 323,311
2024-02-13 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise +6,630 105,792
2024-02-13 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise · Restricted Share Units −6,630 0
2024-02-01 Weiss Amir Chief Accounting Officer Sale −31,766 $12.37 $393K 10,676
2024-01-30 Daniell Richard Exec. VP, European Commercial Grant or award · Restricted Share Units +55,226 55,226
2024-01-30 Kalif Eliyahu Sharon EVP, Chief Financial Officer Grant or award · Restricted Share Units +52,320 52,320
2024-01-30 Drape Eric Executive VP Global Operations Grant or award · Restricted Share Units +55,226 55,226
2024-01-30 Sabag Mark EVP, International Markets Grant or award · Restricted Share Units +58,133 58,133
2023-11-20 Fox Christine EVP, Head of U.S. Commercial Grant or award · Restricted Share Units +253,968 253,968
2023-11-15 Conway Vikki L See "Remarks" Grant or award · Restricted Share Units +33,482 33,482
2023-11-15 Bergwerk Dov Acting Chief Legal Officer Grant or award · Restricted Share Units +33,482 33,482
2023-09-02 Shalev Varda Director Grant or award · Restricted Share Units +12,872 12,872
2023-08-09 Grant Angus EVP, Business Development Grant or award · Restricted Share Units +51,652 51,652
2023-08-07 Kalif Eliyahu Sharon EVP, Chief Financial Officer Sale −35,125 $9.73 $342K 99,162
2023-08-04 Weiss Amir Chief Accounting Officer Sale −1,981.41 $9.92 $20K 42,442
2023-08-04 Zaks Tal Zvi Director Option exercise +15,810 28,032
2023-08-04 Zaks Tal Zvi Director Option exercise · Restricted Share Units −15,810 0
2023-08-04 Vergis Janet S. Director Option exercise +15,810 42,957

Page 26 of 76 · 1,517 trades